东诚药业：实际控制人由守谊累计质押约2858万股

Group 1 - The core business of Dongcheng Pharmaceutical is entirely focused on the biopharmaceutical industry, with a revenue composition of 100% from this sector for the first half of 2025 [1] Group 2 - Dongcheng Pharmaceutical announced on August 21 that its actual controller, Mr. You Shouyi, has pledged part of his shares for extension. As of August 21, 2025, he holds approximately 103 million shares of Dongcheng Pharmaceutical, with a total of about 28.58 million shares pledged, accounting for 27.66% of his total holdings. The overall risk of share pledge is manageable, and there is currently no risk of forced liquidation [3]